Karyopharm Therapeutics Inc. Public Float
Karyopharm Therapeutics Inc. (KPTI) had Public Float of $37.00 million as of 2025-06-30, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-13
- 2025-06-30: Entity Public Float $37.00M.
- 2024-06-30: Entity Public Float $107.60M.
- 2023-06-30: Entity Public Float $201.10M.
- 2022-06-30: Entity Public Float $351.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $37.00M 10-K · filed 2026-02-13 |
| 2024-06-30 | $107.60M 10-K · filed 2025-02-19 |
| 2023-06-30 | $201.10M 10-K · filed 2024-02-29 |
| 2022-06-30 | $351.30M 10-K · filed 2023-02-17 |
| 2021-06-30 | $738.50M 10-K · filed 2022-03-01 |
| 2020-06-30 | $1.32B 10-K · filed 2021-02-24 |
| 2019-06-30 | $343.52M 10-K · filed 2020-02-26 |
| 2018-06-30 | $820.96M 10-K · filed 2019-02-28 |
| 2017-06-30 | $316.15M 10-K · filed 2018-03-15 |
| 2016-06-30 | $159.92M 10-K · filed 2017-03-16 |
| 2015-06-30 | $628.26M 10-K · filed 2016-03-15 |
| 2014-06-30 | $580.37M 10-K · filed 2015-03-13 |
| 2013-06-30 | $0.00 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |